Suppr超能文献

影响急性缺血性脑卒中血管内取栓治疗决策的因素。

Factors Associated With the Decision-Making on Endovascular Thrombectomy for the Management of Acute Ischemic Stroke.

机构信息

From the Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Canada (G.S.).

Department of Clinical Neurosciences, University of Calgary, Canada (B.K.M., M.A., M.M.F., A.M.D., M.D.H., M.G.).

出版信息

Stroke. 2019 Sep;50(9):2441-2447. doi: 10.1161/STROKEAHA.119.025631. Epub 2019 Jul 22.

Abstract

Background and Purpose- Little is known about the real-life factors that clinicians use in selection of patients that would receive endovascular treatment (EVT) in the real world. We sought to determine patient, practitioner, and health system factors associated with therapeutic decisions around endovascular treatment. Methods- We conducted a multinational cross-sectional web-based study comprising of 607 clinicians and interventionalists from 38 countries who are directly involved in acute stroke care. Participants were randomly allocated to 10 from a pool of 22 acute stroke case scenarios. Each case was classified as either Class I, Class II, or unknown evidence according to the current guidelines. We used logistic regression analysis applying weight of evidence approach. Main outcome measures were multilevel factors associated with EVT, adherence to current EVT guidelines, and practice gaps between current and ideal practice settings. Results- Of the 1330 invited participants, 607 (45.6%) participants completed the study (53.7% neurologists, 28.5% neurointerventional radiologists, 17.8% other clinicians). The weighed evidence approach revealed that National Institutes of Health Stroke Scale (34.9%), level of evidence (30.2%), ASPECTS (Alberta Stroke Program Early CT Score) or ischemic core volume (22.4%), patient's age (21.6%), and clinicians' experience in EVT use (19.3%) are the most important factors for EVT decision. Of 2208 responses that met Class I evidence for EVT, 1917 (86.8%) were in favor of EVT. In case scenarios with no available guidelines, 1070 of 1380 (77.5%) responses favored EVT. Comparison between current and ideal practice settings revealed a small practice gap (941 of 6070 responses, 15.5%). Conclusions- In this large multinational survey, stroke severity, guideline-based level of evidence, baseline brain imaging, patients' age and physicians' experience were the most relevant factors for EVT decision-making. The high agreement between responses and Class I guideline recommendations and high EVT use even when guidelines were not available reflect the real-world acceptance of EVT as standard of care in patients with disabling acute ischemic stroke.

摘要

背景与目的- 对于临床医生在现实世界中选择接受血管内治疗(EVT)的患者时实际使用的因素,我们知之甚少。我们旨在确定与血管内治疗治疗决策相关的患者、医生和医疗体系因素。

方法- 我们进行了一项多国家、基于网络的横断面研究,包括来自 38 个国家的 607 名直接参与急性脑卒中护理的临床医生和介入医生。参与者从 22 个急性脑卒中病例情景中随机分配到 10 个。根据当前指南,每个病例被分为 I 类、II 类或未知证据。我们使用逻辑回归分析应用证据权重方法。主要观察指标是与 EVT 相关的多水平因素、对当前 EVT 指南的依从性以及当前和理想实践环境之间的实践差距。

结果- 在邀请的 1330 名参与者中,有 607 名(45.6%)完成了研究(53.7%神经科医生、28.5%神经介入放射科医生、17.8%其他临床医生)。加权证据方法显示,美国国立卫生研究院卒中量表(34.9%)、证据水平(30.2%)、ASPECTS(阿尔伯塔卒中项目早期 CT 评分)或缺血核心体积(22.4%)、患者年龄(21.6%)和医生 EVT 使用经验(19.3%)是 EVT 决策的最重要因素。在满足 EVT 一级证据的 2208 个病例中,1917 个(86.8%)支持 EVT。在无可用指南的病例中,1380 个病例中有 1070 个(77.5%)支持 EVT。当前与理想实践环境的比较显示实践差距较小(6070 个病例中有 941 个,15.5%)。

结论- 在这项大型多国家调查中,卒中严重程度、基于指南的证据水平、基线脑影像学、患者年龄和医生经验是 EVT 决策的最重要因素。在没有指南的情况下,EVT 的高使用率和对 I 级指南建议的高一致性反映了 EVT 在有残疾的急性缺血性卒中患者中作为标准治疗的现实世界接受程度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验